EnLyte Monotherapy Reduces Toxic Homocysteine in Patients With MTHFR Polymorphism: Breakthrough Study Shows Significant Reduction In Toxic Amino Acid Linked To Hundreds Of Diseases SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- A new study shows patients with the MTHFR C677T/A1298C enzyme polymorphism significantly benefit from reduced B vitamin therapy, marketed under the...

New Study Shows Homocysteine Reduction Directly Correlates With Higher Remission Rates in Depression SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- It has been common knowledge in the medical community that administering B9 (folates), B12, and B6 will lower homocysteine levels in the body. However,...